MRNA - COVID-19 vaccine makers rebound amid post-pandemic prospects
2024-05-22 14:00:26 ET
More on BioNTech, Moderna, etc.
- Pfizer: Offsetting The LOE Cliff Crisis With 6 New Potential Blockbuster Drugs
- Aggressive Strides Forward For Moderna's Cancer Vaccine
- Pfizer Stock: Rebound Has Started (Technical Analysis)
- Pfizer launching cost reduction program expected to rein in $1.5B by end of 2027
- Pfizer tax practices targeted by Senate Finance Committee Chair Wyden